Compound: Cediranib

Drug Target: VEGFR, FLT1, FLT2, FLT3, FLT4, KIT, PDGFRB

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.